Kinesin superfamily protein expression and its association with progression and prognosis in hepatocellular carcinoma
- 1 January 2017
- journal article
- research article
- Published by Medknow in Journal of Cancer Research and Therapeutics
- Vol. 13 (4), 651-659
- https://doi.org/10.4103/jcrt.jcrt_491_17
Abstract
Objectives: In this study, we characterized the expression of 32 other kinesin superfamily proteins (KIFs) and analyzed their association with the progression and prognosis of hepatocellular carcinoma (HCC). Materials and Methods: The data from 295 HCC patients from The Cancer Genome Atlas were included in the study. An independent t-test was used to compare the KIF levels in HCC and adjacent tissues. Pearson's Chi-square test was used to assess the relationships of KIF expression with tumor biomarkers and clinicopathological parameters. Kaplan–Meier plots and log-rank tests were used to analyze survival, and univariate and multivariate analyses were used to identify independent prognostic factors. Results: The expressions of 32 KIFs were compared between HCC and adjacent nontumor tissues. Among them, 12 KIFs showed no statistical significance, 17 KIFs were upregulated, and three KIFs were downregulated in tumor tissues. The levels of some KIFs were markedly correlated with that of biomarkers for the S phase and proliferation. KIF2A and KIFC3 expression was positively associated with biomarkers for cell invasion and migration. Some KIF overexpression was significantly associated with neoplastic pathological grade and tumor-node-metastasis staging. Furthermore, KIF2C, KIF4A, and KIF11 overexpression were significantly associated with shorter relapse-free survival times. KIF2A, KIF2C, KIF3A, KIF4B, KIF11, KIF15, KIFC1, and KIFC3 overexpression was associated with shorter overall survival (OS) times, whereas higher expression of KIF19 was associated with a longer OS time. Further multivariate analyses suggested that only KIF4B was an independent prognostic factor for HCC. Conclusions: Most overexpressions of abnormal KIFs were significantly associated with HCC progression and prognosis, indicating that KIFs could be prognostic and therapeutic biomarkers for HCC. However, it is necessary to further study the function of KIFs and their mechanisms involved in HCC.Keywords
This publication has 33 references indexed in Scilit:
- Cancers with increasing incidence trends in the United States: 1999 through 2008CA: A Cancer Journal for Clinicians, 2012
- The role of kinesin family proteins in tumorigenesis and progressionCancer, 2010
- Traffic control: regulation of kinesin motorsNature Reviews Molecular Cell Biology, 2009
- The Expression of Three Genes in Primary Non–Small Cell Lung Cancer Is Associated with Metastatic Spread to the BrainClinical Cancer Research, 2009
- The kinesin KIF1Bβ acts downstream from EglN3 to induce apoptosis and is a potential 1p36 tumor suppressorGenes & Development, 2008
- Activation of KIF4A as a Prognostic Biomarker and Therapeutic Target for Lung CancerClinical Cancer Research, 2007
- Clinicopathological and biological significance of mitotic centromere-associated kinesin overexpression in human gastric cancerBritish Journal of Cancer, 2007
- Analysis of the kinesin superfamily: insights into structure and functionTrends in Cell Biology, 2005
- Functional Analysis of Human Microtubule-based Motor Proteins, the Kinesins and Dyneins, in Mitosis/Cytokinesis Using RNA InterferenceMolecular Biology of the Cell, 2005
- Centrosome control of the cell cycleTrends in Cell Biology, 2005